Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026827 (
hypotonia
)
5,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Multiple TREX mRNA export complex subunits (e.g.,
THOC1
, THOC2, THOC5, THOC6, THOC7) have now been implicated in neurodevelopmental disorders (NDDs), neurodegeneration and cancer. We previously implicated missense and splicing-defective
THOC2
variants in NDDs and a broad range of other clinical features. Here we report 10 individuals from nine families with rare missense
THOC2
variants including the first case of a recurrent variant (p.Arg77Cys), and an additional individual with an intragenic
THOC2
microdeletion (Del-Ex37-38).
Ex vivo
missense variant testing and patient-derived cell line data from current and published studies show 9 of the 14 missense THOC2 variants result in reduced protein stability. The splicing-defective and deletion variants result in a loss of small regions of the C-terminal THOC2 RNA binding domain (RBD). Interestingly, reduced stability of THOC2 variant proteins has a flow-on effect on the stability of the multi-protein TREX complex; specifically on the other NDD-associated THOC subunits. Our current, expanded cohort refines the core phenotype of THOC2 NDDs to language disorder and/or ID, with a variable severity, and disorders of growth. A subset of affected individuals' has severe-profound ID, persistent
hypotonia
and respiratory abnormalities. Further investigations to elucidate the pathophysiological basis for this severe phenotype are warranted.
...
PMID:Expanding Clinical Presentations Due to Variations in THOC2 mRNA Nuclear Export Factor. 3211 45